Adrian R. Krainer's Insider Trades & SAST Disclosures

Adrian R. Krainer's most recent trade in Stoke Therapeutics Inc was a trade of 40,472 Common Stock done at an average price of $29.7 . Disclosure was reported to the exchange on Nov. 24, 2025.

Share

Note

This is a custom search result for pattern Adrian R. Krainer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Stoke Therapeutics Inc	Adrian R. Krainer	Director	Sale of securities on an exchange or to another person at price $ 29.72 per share.	24 Nov 2025	40,472	323,774 (0%)	0%	29.7	1,202,719	Common Stock
Stoke Therapeutics Inc	Adrian R. Krainer	Director	Sale of securities on an exchange or to another person at price $ 27.34 per share.	14 Nov 2025	20,682	364,246 (1%)	0%	27.3	565,365	Common Stock
Stoke Therapeutics Inc	Adrian R. Krainer	Director	Sale of securities on an exchange or to another person at price $ 26.61 per share.	14 Nov 2025	19,790	384,928 (1%)	0%	26.6	526,693	Common Stock
Stoke Therapeutics Inc	Adrian R. Krainer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2025	29,747	29,747	-		-	Director Stock Option (Right to Buy)
Stoke Therapeutics Inc	Adrian R. Krainer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	7,639	7,639	-		-	Director Stock Option (Right to Buy)
Stoke Therapeutics Inc	Adrian R. Krainer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2023	19,441	19,441	-		-	Director Stock Option (Right to Buy)
Stoke Therapeutics Inc	Adrian R. Krainer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2022	21,000	21,000	-		-	Director Stock Option (Right to Buy)
Stoke Therapeutics Inc	Adrian R. Krainer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2021	11,650	11,650	-		-	Director Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades